Clinical Trials on Antibiotic-induced Epithelial Barrier Disintegrity

Total 132 results

Seed Health

Completed

Metagenomic and Metabolomic Reconstitution of Gut Microbiota After Broad Spectrum Antibiotic Therapy

Antibiotic-associated Diarrhea | Antibiotic Side Effect | Antibiotic-induced Dysbiosis | Antibiotic-induced Epithelial Barrier Disintegrity

Canada
Masonic Cancer Center, University of Minnesota

Completed

Gut Microbiota in Intestinal Barrier Damage in Acute Leukemia Patients Undergoing Inpatient Induction

Acute Leukemia | Chemotherapy-Induced Gut Barrier Damage

United States
Huazhong University of Science and Technology
Fuyong People's Hospital, Bao 'an District, Shenzhen City, Guangdong

Completed

Intervention on Non-prescription Antibiotic Use Among the Public

Antibiotic Use | Non-Prescription Drug Misuse

China
The Republican Research and Practical Center for...

Unknown

Improved Basophil Activation Test (BAT) in the Diagnostics of Drug Allergy

Antibiotic Allergy | Drug Allergy | NSAID-Induced Anaphylactoid Reaction

Belarus
Montefiore Medical Center

Completed

Drug Challenges Without Prior Skin Testing

Drug Hypersensitivity | Penicillin Allergy | Antibiotic Allergy

United States
National Cancer Institute (NCI)
NRG Oncology

Completed

Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | BRCA1 Mutation Carrier | BRCA2 Mutation Carrier | Ovarian Epithelial Tumor

United States
University of Southern Denmark
Hospital of South West Jutland

Not yet recruiting

Comparison of Three Different Antibiotic Treatments Against Recurrent Urinary Tract Infections in Catheterized Patients

Recurrent Urinary Tract Infections | Antibiotic Treatment | Chronic Urinary-catheter-carrier | Biofilm Infection | Replacement of Urinary Catheter
Women and Infants Hospital of Rhode Island

Completed

Lysophosphatidic Acid Assay in Patients With Ovarian Cancer or Who Are at Risk for Ovarian Cancer

Ovarian Cancer | brca1 Mutation Carrier | brca2 Mutation Carrier

United States
University of Alabama at Birmingham
National Cancer Institute (NCI)

Withdrawn

Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy

Ovarian Cancer | brca1 Mutation Carrier | brca2 Mutation Carrier

United States
University of Arizona
National Cancer Institute (NCI)

Completed

Fenretinide in Preventing Ovarian Cancer in Participants Who Are at High Risk for Developing Ovarian Cancer and Planning to Undergo Surgery to Remove the Ovaries

Ovarian Cancer | brca1 Mutation Carrier | brca2 Mutation Carrier

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Study of Antibiotic-induced Vaginal Yeast Infections in Healthy Women

Vaginal Candidiasis | Microbiome | Antibiotic-Induced VVC

United States
Nadeem Iqbal
Ahmad Zia; Muhammad Junaid Tahir

Recruiting

Prophylactic Antibiotic Use in Transarterial Chemoembolization for Hepatocellular Carcinoma

Antibiotic Prophylaxis

Pakistan
Cancer Research UK

Completed

Rucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian Cancer

Breast Cancer | Ovarian Cancer | brca1 Mutation Carrier | brca2 Mutation Carrier

United Kingdom
Catholic University of the Sacred Heart

Unknown

Study With Trabectedin in BRCA1 and BRCA2 Mutation Carrier and BRCAness Phenotype Ovarian Cancer (MITO15)

BRCA1 and BRCA2 Mutation Carrier and BRCAness Phenotype

Italy
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Active, not recruiting

Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer

Ductal Breast Carcinoma in Situ | BRCA1 Mutation Carrier | BRCA2 Mutation Carrier | Atypical Ductal Breast Hyperplasia | Lobular Breast Carcinoma in Situ

United States
University of Southern California
National Cancer Institute (NCI); California Breast Cancer Research Program

Completed

Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer

Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Ductal Breast Carcinoma in Situ | BRCA1 Mutation Carrier | BRCA2 Mutation Carrier | Lobular Breast Carcinoma in Situ

United States
University of Washington
National Cancer Institute (NCI); National Institute of Nursing Research (NINR)

Completed

Group-Based Lifestyle Intervention in Measuring Biomarker Levels in Participants at High Risk for Breast Cancer (DEEM)

Ductal Breast Carcinoma in Situ | BRCA1 Mutation Carrier | BRCA2 Mutation Carrier | Atypical Ductal Breast Hyperplasia | Lobular Breast Carcinoma in Situ | Atypical Lobular Breast Hyperplasia

United States
Translational Research Center for Medical Innovation...
Okayama University; Japanese Gynecologic Oncology Group (JGOG)

Recruiting

Prospective Cohort Study of Germline Variant Carriers With BRCA1 or BRCA2

Fallopian Tube Carcinoma | Peritoneal Carcinoma | Ovarian Carcinoma | BRCA1 and/or BRCA2 Variant Carriers

Japan
Assiut University

Completed

Immune Responses in Hepatocellular Carcinoma Patients After Treatment With Direct Acting Antiviral Drugs

Drug-Induced Liver Injury

Egypt
Northwestern University
National Cancer Institute (NCI)

Completed

Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy

Stage 0 Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Lobular Breast Carcinoma In Situ | Ductal Breast Carcinoma In Situ | BRCA1 Mutation Carrier | BRCA2 Mutation Carrier

United States
Laura Fanucchi

Completed

Combining Opioid Addiction Treatment Services With CARe for Infectious Endocarditis (CATS-CARE)

Endocarditis, Bacterial | Opioid-use Disorder | Outpatient Parenteral Antibiotic Therapy | Buprenorphine

United States
OHSU Knight Cancer Institute
Oregon Health and Science University

Not yet recruiting

StrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer Patients

Breast Carcinoma | Head and Neck Carcinoma | Radiation-Induced Dermatitis

United States
National Cancer Institute (NCI)

Completed

Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Breast Carcinoma | Ovarian Carcinoma | Pancreatic Carcinoma | Prostate Carcinoma | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative... and other conditions

United States
St. Joseph's Hospital and Medical Center, Phoenix
The Cleveland Clinic; Thomas Jefferson University

Recruiting

Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions (POET)

Pituitary Adenoma | Antibiotics

United States
Centro di Ricerca Clinica Salentino

Active, not recruiting

Epigallocatechin Gallate and Other Antural Compounds in HPV Infections (EGCGHPV)

Papilloma-induced Cervical Lesions

Italy
The First People's Hospital of Changzhou

Not yet recruiting

Effect of Cytokine-induced Killer Cells for Stage I-II Malignant Gliomas

Cytokine-Induced Killer Cells | Milignant Gliomas
The First People's Hospital of Changzhou

Not yet recruiting

Effect of Cytokine-induced Killer Cells for Advanced Malignant Gliomas

Cytokine-Induced Killer Cells | Advanced Milignant Gliomas
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Uterine Corpus Carcinoma | Endometrial Adenocarcinoma | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast... and other conditions

United States
Gary Morrow
National Cancer Institute (NCI)

Completed

Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer (Curcumin-II)

Pain | Breast Carcinoma | Stage 0 Breast Cancer | Radiation-Induced Dermatitis

United States
Lei Li
Beijing Hospital; China-Japan Friendship Hospital; Navy General Hospital, Beijing and other collaborators

Unknown

Granulocyte Colony Stimulating Factor for for the Prevention of Febrile Neutropenia in Epithelial Ovarian Cancer

Quality of Life | Epithelial Ovarian Cancer | Chemotherapy-induced Neutropenia | Overall Survival | Progression-free Survival | Febrile Neutropenia, Drug-Induced | Colony Stimulating Factors Adverse Reaction | Granulocyte Colony Stimulating Factor | Cost-effectiveness Analysis

China
National Cancer Institute (NCI)

Terminated

Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific | Adenocarcinoma of the Pancreas | Recurrent Pancreatic Cancer | Stage IV Pancreatic Cancer | Stage IV Breast Cancer | Stage IV Ovarian Epithelial Cancer | Stage IV Ovarian Germ Cell Tumor | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB... and other conditions

United States
Oslo University Hospital
Swedish Orphan Biovitrum

Completed

Trabectedin/Caelyx vs Cisplatin Hypersensitivity in Relapsed Ovarian Cancer Patients Allergic to Platinum (TvsCH)

Chemotherapy-induced Nausea and Vomiting | Chemotherapy Effect | Chemotherapeutic Toxicity | Ovarian Neoplasm | Chemotherapy-induced Neutropenia
Heath Skinner

Completed

Low Level Laser Therapy for Radiation Induced Dermatitis in H & N Squamous Cell Carcinoma

Radiation Dermatitis

United States
Zhejiang University
Shulan (Hangzhou) Hospital

Not yet recruiting

Assessment of AFP and PIVKA-II as Prognostic Indicators in Liver Transplantation for Hepatocellular Carcinoma

Liver Transplantation | Hepatocellular Carcinoma | Alpha-Fetoprotein | Protein Induced by Vitamin K Absence or Antagonist-II
Duke University
TerSera Therapeutics

Completed

Rolapitant as an Antiemetic in Malignant Glioma Patients Receiving Radiotherapy and Temozolomide

Chemo-radiation Induced Nausea and Vomiting

United States
Nanfang Hospital, Southern Medical University

Recruiting

A Mucosal Contouring Method Based on Swallowing-induced Breakthrough Pain for Radiation-induced Oropharyngeal Mucositis

Radiation-induced Oropharyngeal Mucositis | Swallowing-induced Breakthrough Pain

China
City of Hope Medical Center
National Cancer Institute (NCI)

Not yet recruiting

Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors

Breast Carcinoma | Chemotherapy-Induced Peripheral Neuropathy | Colon Carcinoma

United States
Nanfang Hospital, Southern Medical University

Recruiting

A Real-world Observational Study of a Mucosal Contouring Method for Radiation-induced Oropharyngeal Mucositis

Radiation-induced Oropharyngeal Mucositis | Swallowing-induced Breakthrough Pain

China
Samsung Medical Center
Merck Sharp & Dohme LLC

Completed

Safety and Efficacy of Aprepitant, Ramosetron, and Dexamethasone for Chemotherapy-Induced Nausea and Vomiting in Patients With Ovarian Cancer Treated With Taxane/Carboplatin

Ovarian Cancer | Chemotherapy-Induced Nausea and Vomiting

Korea, Republic of
University of Lausanne Hospitals

Completed

Indocyanine Green and Portal Pressure in Viral and Alcoholic Cirrhotic Patients With Hepatocarcinoma

Carcinoma, Hepatocellular | Alcoholic Cirrhosis | Viral Cirrhosis | Postoperative Hepatic Failure

Switzerland
Assistance Publique - Hôpitaux de Paris

Terminated

Phlebotomy and Risk of Hepatocellular Carcinoma in Patients With Compensated Alcoholic Cirrhosis (CIRROX)

Iron Overload | Alcoholic Cirrhosis

France
University Hospital, Toulouse

Completed

Evaluation of the Improvement of Quality of Life of Patients Suffering From Hailey Hailey or Darier Disease After Injections of Botulism Toxin Into Large Folds. (ToxHD)

Darier Disease | Hailey-Hailey Disease
Tianjin Medical University Cancer Institute and...

Completed

A Standardized Intervention to Improve the Management of Chemotherapy-induced Nausea and Vomiting

Squamous Cell Carcinoma of Head and Neck | Chemotherapy Induced Nausea and Vomiting

China
TerSera Therapeutics LLC

Completed

Real-world Evidence Study EvaLuating PAtient-Reported Outcomes With XERMELO (RELAX)

Carcinoid Syndrome

United States
Novartis Pharmaceuticals

Completed

Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor (RADIANT-2)

Carcinoid Tumor | Malignant Carcinoid Syndrome

France, Spain, Netherlands, United States, Canada, Sweden, Italy, Australia, Germany, Greece, Belgium, Czech Republic, Slovakia, Finland, United Kingdom
Lexicon Pharmaceuticals

Completed

An Open-label Study to Evaluate the Absorption, Metabolism, and Excretion of [14C]-Telotristat Etiprate in Males (LX1606-104)

Carcinoid Syndrome

United Kingdom
National Cancer Institute (NCI)

Completed

A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area

Hepatitis, Viral, Human | Carcinoma, Hepatocellular | Hepatitis, Chronic | Hepatitis, Alcoholic | Liver Cirrhosis, Alcoholic

United States
Sun Yat-sen University

Completed

Impact on Xerostomia for Nasopharyngeal Carcinoma Patients Treated With or Without Superficial Parotid Lobe-sparing Intensity-modulated Radiotherapy

Nasopharyngeal Carcinoma | Radiation-induced Xerostomia

China
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Azilect + Antidepressant Chart Review (STACCATO)

Serotonin Syndrome
Ipsen

Completed

Study to Evaluate the Use of Resources and the Costs Associated With Carcinoid Syndrome (CS) in Patients With NETs in Spain (RECOSY)

Neuroendocrine Tumors

Spain

Clinical Trials on Antibiotic-induced Epithelial Barrier Disintegrity

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Senegal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations